Dolby Laboratories Common Stock (DLB)
EBITDA Margin
27.53%
TTM · Period ending:
DLB EBITDA Margin
Latest reported27.53%period ending
Latest reported27.53%period ending
DLB TTM EBITDA Margin (22.52% → 27.53%)
TTM ebitda margin
High-resolution chart · PNG
DLB ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 27.5261% | |
| 27.9102% | |
| 28.3141% | |
| 28.7441% | |
| 30.5537% | |
| 31.1633% | |
| 31.1191% | |
| 31.3888% | |
| 27.7082% | |
| 25.6628% | |
| 25.384% | |
| 26.5873% | |
| 28.4157% | |
| 30.8482% | |
| 26.0588% | |
| 25.4339% | |
| 27.8007% | |
| 28.6546% | |
| 32.6265% | |
| 37.4643% | |
| 36.0077% | |
| 35.3078% | |
| 35.6587% | |
| 28.4554% | |
| 29.231% | |
| 27.9446% | |
| 28.2539% | |
| 29.5928% | |
| 27.6% | |
| 25.3378% | |
| 24.163% | |
| 26.3282% | |
| 27.0979% | |
| 33.8332% | |
| 33.0053% | |
| 31.5296% | |
| 32.344% | |
| 31.866% | |
| 33.3483% | |
| 31.43% | |
| 34.2889% | |
| 32.0006% | |
| 31.13% | |
| 32.3225% | |
| 31.568% | |
| 31.9083% | |
| 33.6439% | |
| 34.3331% | |
| 34.7426% | |
| 34.4694% | |
| 33.6777% | |
| 33.8899% | |
| 34.8653% | |
| 36.9901% | |
| 40.1068% | |
| 43.4729% | |
| 47.4758% | |
| 49.6736% | |
| 50.0397% | |
| 50.43% | |
| 49.5365% | |
| 49.3585% | |
| 51.1639% | |
| 51.4557% | |
| 50.4365% | |
| 50.5749% | |
| 49.8123% | |
| 54.3481% | |
| 54.1858% | |
| 54.9064% | |
| 40.9209% | |
| 35.1078% | |
| 34.5846% | |
| 31.3249% | |
| 42.5046% | |
| 39.1139% | |
| 39.9171% | |
| 38.3187% | |
| 37.5352% | |
| 35.4304% | |
| 31.7371% | |
| 32.9472% | |
| 28.9691% | |
| 27.8421% | |
| -0.937% | |
| 5.5442% | |
| 15.2994% | |
| 23.5946% | |
| 33.1855% | |
| 29.8826% | |
| 25.5377% | |
| 22.5211% |